Aggregated
46% success rate- Bullish
- 0
- Hold
- 0
- Bearish
- 0
Guggenheim
A Guggenheim analyst with 32 tracked ratings covering 26 distinct tickers has a 50% success rate on the captured sample, primarily issuing 20 bullish ratings across the analyzed sectors.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| RLAY | 2026-05-26 | buy | $26.00 | Aggregated |
| OLMA | 2026-05-13 | buy | $35.00 | Aggregated |
| BCAX | 2026-05-11 | buy | $42.00 | Aggregated |
| JANX | 2026-05-08 | buy | $58.00 | Aggregated |
| CELC | 2026-05-04 | buy | $165.00 | Aggregated |
| TYRA | 2026-04-15 | buy | $54.00 | Aggregated |
| RLAY | 2026-03-13 | buy | $22.00 | Aggregated |
| CGEM | 2026-02-02 | buy | $30.00 | Aggregated |
| CBIO | 2026-01-21 | buy | $35.00 | Aggregated |
| BDTX | 2025-12-04 | hold | - | Aggregated |
| NUVL | 2025-11-18 | buy | $155.00 | Aggregated |
| NUVLNUVALENT INC - ORDINARY SHARES - CLASS A | 2025-11-18 | unknown | $155.00 | Aggregated |
| PYXS | 2025-11-04 | buy | $7.00 | Aggregated |
| PYXSPYXIS ONCOLOGY INC | 2025-11-04 | unknown | $7.00 | Aggregated |
| SMMT | 2025-10-22 | buy | $40.00 | Aggregated |
| SMMTSUMMIT THERAPEUTICS INC | 2025-10-22 | unknown | $40.00 | Aggregated |
| CGON | 2025-10-08 | buy | $90.00 | Aggregated |
| CGONCG ONCOLOGY INC. | 2025-10-08 | unknown | $90.00 | Aggregated |
| OLMAOLEMA PHARMACEUTICALS INC | 2025-10-08 | unknown | $20.00 | Aggregated |
| CELC | 2025-09-22 | buy | $110.00 | Aggregated |
| BDTX | 2025-09-04 | buy | $8.00 | Aggregated |
| BDTXBLACK DIAMOND THERAPEUTICS INC | 2025-09-04 | unknown | $8.00 | Aggregated |
| CCCC | 2025-09-04 | buy | $8.00 | Aggregated |
| CCCCC4 THERAPEUTICS INC | 2025-09-04 | unknown | $8.00 | Aggregated |
| JANXJANUX THERAPEUTICS INC | 2025-09-04 | unknown | $72.00 | Aggregated |
| KURA | 2025-09-04 | hold | - | Aggregated |
| NUVL | 2025-09-04 | buy | $122.00 | Aggregated |
| NUVLNUVALENT INC - ORDINARY SHARES - CLASS A | 2025-09-04 | unknown | $122.00 | Aggregated |
| ORIC | 2025-09-04 | buy | $18.00 | Aggregated |
| ORICORIC PHARMACEUTICALS INC | 2025-09-04 | unknown | $18.00 | Aggregated |
| PYXS | 2025-09-04 | buy | $5.00 | Aggregated |
| RLAY | 2025-09-04 | buy | $15.00 | Aggregated |
| RLAYRELAY THERAPEUTICS INC | 2025-09-04 | unknown | $15.00 | Aggregated |
| SMMT | 2025-09-04 | buy | $40.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| RLAY | 3 | 2026-05-26 | Aggregated |
| OLMA | 1 | 2026-05-13 | Aggregated |
| BCAX | 1 | 2026-05-11 | Aggregated |
| JANX | 1 | 2026-05-08 | Aggregated |
| CELC | 2 | 2026-05-04 | Aggregated |
| TYRA | 1 | 2026-04-15 | Aggregated |
| CGEM | 1 | 2026-02-02 | Aggregated |
| CBIO | 1 | 2026-01-21 | Aggregated |
| BDTX | 2 | 2025-12-04 | Aggregated |
| NUVL | 2 | 2025-11-18 | Aggregated |
| NUVLNUVALENT INC - ORDINARY SHARES - CLASS A | 2 | 2025-11-18 | Aggregated |
| PYXS | 2 | 2025-11-04 | Aggregated |
| PYXSPYXIS ONCOLOGY INC | 1 | 2025-11-04 | Aggregated |
| SMMT | 2 | 2025-10-22 | Aggregated |
| SMMTSUMMIT THERAPEUTICS INC | 1 | 2025-10-22 | Aggregated |
| CGON | 1 | 2025-10-08 | Aggregated |
| CGONCG ONCOLOGY INC. | 1 | 2025-10-08 | Aggregated |
| OLMAOLEMA PHARMACEUTICALS INC | 1 | 2025-10-08 | Aggregated |
| BDTXBLACK DIAMOND THERAPEUTICS INC | 1 | 2025-09-04 | Aggregated |
| CCCC | 1 | 2025-09-04 | Aggregated |
| CCCCC4 THERAPEUTICS INC | 1 | 2025-09-04 | Aggregated |
| JANXJANUX THERAPEUTICS INC | 1 | 2025-09-04 | Aggregated |
| KURA | 1 | 2025-09-04 | Aggregated |
| ORIC | 1 | 2025-09-04 | Aggregated |
| ORICORIC PHARMACEUTICALS INC | 1 | 2025-09-04 | Aggregated |
| RLAYRELAY THERAPEUTICS INC | 1 | 2025-09-04 | Aggregated |